Biography and Research Information
OverviewAI-generated summary
Fatima Ayub's research focuses on identifying biomarkers for adverse outcomes in patients undergoing cardiac surgery, particularly concerning acute kidney injury. Her work has investigated the predictive value of urinary complement C3 and vitamin D-binding protein for these outcomes. Ayub has also explored various clinical scenarios, including rare drug complications like eptifibatide-induced thrombocytopenia and effective treatments for hypermagnesemia. Her publications also touch upon therapeutic strategies for COVID-19 and patient-centered approaches in dialysis care. Ayub has an h-index of 3, with 27 total publications and 31 citations. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Manisha Singh and Joseph H. Holthoff, and also with Makenzie Kapales at the University of Arkansas at Fayetteville.
Metrics
- h-index: 3
- Publications: 27
- Citations: 31
Selected Publications
-
SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series (2025)
-
Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy (2025)
-
Addressing the barriers to peritoneal dialysis—Visual appeal matters (2025)
-
Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery (2024)
-
I Am the Lucky Third: Spontaneous Resolution of High-Risk Membranous Nephropathy (2023)
-
Triple Jeopardy: Trialled Thrice in the Same Crime (2023)
-
The Drug that Keeps Giving: Hypomagnesemia Fixed by SGLT2 Inhibitor (2023)
-
ANCA-Associated Vasculitis Recurrence After Kidney Transplantation (2023)
-
State Advisory Council: Stakeholders’ Perspective for Shaping the Future of Chronic Kidney Disease Patients in Arkansas (2023)
-
Hemodialysis Is More Effective Than Continuous Venovenous Hemodialysis for Treatment of Hypermagnesemia due to Epsom Salt Ingestion (2022)
-
The Disparities Map: It’s Gone South! (2022)
-
Addressing Barriers to Peritoneal Dialysis: Can It Look Pretty? (2022)
Collaboration Network
Top Collaborators
Manisha Singh
University of Arkansas Medical Center
4 shared publications
In database
- State Advisory Council: Stakeholders’ Perspective for Shaping the Future of Chronic Kidney Disease Patients in Arkansas
- Addressing Barriers to Peritoneal Dialysis: Can It Look Pretty?
- The Disparities Map: It’s Gone South!
- Addressing the barriers to peritoneal dialysis—Visual appeal matters
Joseph H. Holthoff
3 shared publications
In database
- Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery
- The Drug that Keeps Giving: Hypomagnesemia Fixed by SGLT2 Inhibitor
- Hemodialysis Is More Effective Than Continuous Venovenous Hemodialysis for Treatment of Hypermagnesemia due to Epsom Salt Ingestion
Muhammad Hasib Khalil
2 shared publications
- DISSEMINATED BLASTOMYCOSIS PRESENTING AS MONOARTICULAR SEPTIC ARTHRITIS
- HYPERAMMONEMIC COMA IN A PATIENT WITH ORNITHINE TRANSCARBAMYLASE DEFICIENCY
Larissa N. Whale
University of Arkansas at Fayetteville
2 shared publications
In database
- Addressing Barriers to Peritoneal Dialysis: Can It Look Pretty?
- Addressing the barriers to peritoneal dialysis—Visual appeal matters
Makenzie Kapales
University of Arkansas at Fayetteville
2 shared publications
In database
- Addressing Barriers to Peritoneal Dialysis: Can It Look Pretty?
- Addressing the barriers to peritoneal dialysis—Visual appeal matters
Md R. Hasan
University of Arkansas – Fort Smith (US)
2 shared publications
- The Drug that Keeps Giving: Hypomagnesemia Fixed by SGLT2 Inhibitor
- Triple Jeopardy: Trialled Thrice in the Same Crime
Nithin Karakala
University of Arkansas System
2 shared publications
In database
- The Drug that Keeps Giving: Hypomagnesemia Fixed by SGLT2 Inhibitor
- Methotrexate Deja Vu: The Solution Is in the Volume!
Pranav Mahajan
Carle Foundation Hospital (US)
1 shared publication
- Eptifibatide-induced profound thrombocytopaenia: a rare complication
Roxana Azimi
University of Illinois Urbana-Champaign (US)
1 shared publication
- Eptifibatide-induced profound thrombocytopaenia: a rare complication
Naveed Adoni
Carle Foundation Hospital (US)
1 shared publication
- Eptifibatide-induced profound thrombocytopaenia: a rare complication
Wasey Ali Yadullahi Mir
Mount Sinai Hospital (US)
1 shared publication
- A Narrative Review of Existing Options for COVID-19-Specific Treatments
Abdul Hasan Siddiqui
Presbyterian Healthcare Services (US)
1 shared publication
- A Narrative Review of Existing Options for COVID-19-Specific Treatments
Gautam Valecha
Presbyterian Healthcare Services (US)
1 shared publication
- A Narrative Review of Existing Options for COVID-19-Specific Treatments
Shawn Patel
Illinois College (US)
1 shared publication
- A Narrative Review of Existing Options for COVID-19-Specific Treatments
Riddhi Upadhyay
Illinois College (US)
1 shared publication
- A Narrative Review of Existing Options for COVID-19-Specific Treatments
Similar Researchers
Based on overlapping research topics
Otis M. Davis
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Dialysis and Renal Disease Management
Pharmacological Effects and Toxicity Studies
Jerry Ware
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Dialysis and Renal Disease Management
Pharmacological Effects and Toxicity Studies
Nishank Jain
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Dialysis and Renal Disease Management
Pharmacological Effects and Toxicity Studies
Adam Corken
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Dialysis and Renal Disease Management
Pharmacological Effects and Toxicity Studies
Jorge Brito
University of Arkansas for Medical Sciences
Immune Response and Inflammation
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Shi J. Liu
University of Arkansas for Medical Sciences
Immune Response and Inflammation
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies